ABBV Relative Valuation
ABBV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABBV is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for ABBV's competitors is 4.11, providing a benchmark for relative valuation. AbbVie Inc Corp (ABBV) exhibits a P/S ratio of 5.36, which is 30.60% above the industry average. Given its robust revenue growth of 8.39%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is AbbVie Inc (ABBV) currently overvalued or undervalued?
What is AbbVie Inc (ABBV) fair value?
How does ABBV's valuation metrics compare to the industry average?
What is the current P/B ratio for AbbVie Inc (ABBV) as of May 14 2025?
What is the current FCF Yield for AbbVie Inc (ABBV) as of May 14 2025?
What is the current Forward P/E ratio for AbbVie Inc (ABBV) as of May 14 2025?